BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 30322158)

  • 1. Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies.
    Garofalo M; Villa A; Rizzi N; Kuryk L; Mazzaferro V; Ciana P
    Viruses; 2018 Oct; 10(10):. PubMed ID: 30322158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral genome DNA/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic delivery.
    Kwon OJ; Kang E; Kim S; Yun CO
    J Control Release; 2011 Oct; 155(2):317-25. PubMed ID: 21699929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Waugh J; Van Roey M; Jooss K
    Hum Gene Ther; 2009 Oct; 20(10):1201-13. PubMed ID: 19572803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous and cross-species tropism of cancer-derived extracellular vesicles.
    Garofalo M; Villa A; Crescenti D; Marzagalli M; Kuryk L; Limonta P; Mazzaferro V; Ciana P
    Theranostics; 2019; 9(19):5681-5693. PubMed ID: 31534511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment.
    Garofalo M; Saari H; Somersalo P; Crescenti D; Kuryk L; Aksela L; Capasso C; Madetoja M; Koskinen K; Oksanen T; Mäkitie A; Jalasvuori M; Cerullo V; Ciana P; Yliperttula M
    J Control Release; 2018 Aug; 283():223-234. PubMed ID: 29864473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PolySia-Specific Retargeting of Oncolytic Viruses Triggers Tumor-Specific Immune Responses and Facilitates Therapy of Disseminated Lung Cancer.
    Kloos A; Woller N; Gürlevik E; Ureche CI; Niemann J; Armbrecht N; Martin NT; Geffers R; Manns MP; Gerardy-Schahn R; Kühnel F
    Cancer Immunol Res; 2015 Jul; 3(7):751-63. PubMed ID: 25701327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound.
    Bazan-Peregrino M; Rifai B; Carlisle RC; Choi J; Arvanitis CD; Seymour LW; Coussios CC
    J Control Release; 2013 Jul; 169(1-2):40-7. PubMed ID: 23562636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous injection of irradiated tumor cell vaccine carrying oncolytic adenovirus suppressed the growth of multiple lung tumors in a mouse squamous cell carcinoma model.
    Saito A; Morishita N; Mitsuoka C; Kitajima S; Hamada K; Lee KM; Kawabata M; Fujisawa M; Shirakawa T
    J Gene Med; 2011 Jun; 13(6):353-61. PubMed ID: 21674738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect and safety profile of systemically delivered oncolytic adenovirus complexed with EGFR-targeted PAMAM-based dendrimer in orthotopic lung tumor model.
    Yoon AR; Kasala D; Li Y; Hong J; Lee W; Jung SJ; Yun CO
    J Control Release; 2016 Jun; 231():2-16. PubMed ID: 26951927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy.
    Kwon OJ; Kang E; Choi JW; Kim SW; Yun CO
    J Control Release; 2013 Aug; 169(3):257-65. PubMed ID: 23562633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
    Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
    J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice.
    Garofalo M; Villa A; Rizzi N; Kuryk L; Rinner B; Cerullo V; Yliperttula M; Mazzaferro V; Ciana P
    J Control Release; 2019 Jan; 294():165-175. PubMed ID: 30557650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance.
    Cerullo V; Diaconu I; Romano V; Hirvinen M; Ugolini M; Escutenaire S; Holm SL; Kipar A; Kanerva A; Hemminki A
    Mol Ther; 2012 Nov; 20(11):2076-86. PubMed ID: 22828500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
    Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system.
    Aoyama K; Kuroda S; Morihiro T; Kanaya N; Kubota T; Kakiuchi Y; Kikuchi S; Nishizaki M; Kagawa S; Tazawa H; Fujiwara T
    Sci Rep; 2017 Oct; 7(1):14177. PubMed ID: 29074882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors.
    Hakkarainen T; Särkioja M; Lehenkari P; Miettinen S; Ylikomi T; Suuronen R; Desmond RA; Kanerva A; Hemminki A
    Hum Gene Ther; 2007 Jul; 18(7):627-41. PubMed ID: 17604566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for thoracic oncology gone viral.
    Patel MR
    Immunotherapy; 2018 Apr; 10(5):383-390. PubMed ID: 29473469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes.
    Marino N; Illingworth S; Kodialbail P; Patel A; Calderon H; Lear R; Fisher KD; Champion BR; Brown ACN
    PLoS One; 2017; 12(5):e0177810. PubMed ID: 28542292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery systems for enhancing oncolytic adenoviruses efficacy.
    Zhou YC; Zhang YN; Yang X; Wang SB; Hu PY
    Int J Pharm; 2020 Dec; 591():119971. PubMed ID: 33059014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.